[How some commensal bacteria would exacerbate colorectal carcinogenesis?]

Area of Science:

• Microbiology
• Oncology
• Gastroenterology

Background:

• The gut microbiota plays a crucial role in host health, with mutualistic benefits.
• Alterations in gut microbial composition are increasingly recognized as significant factors in colorectal cancer (CRC) development.
• Specific commensal bacteria are implicated in CRC pathogenesis.

Purpose of the Study:

• To review the role of three specific commensal bacterial species in colorectal carcinogenesis.
• To explore the mechanisms by which these bacteria contribute to cancer development, focusing on inflammatory and oncogenic properties.

Main Methods:

• Literature review focusing on Bacteroides fragilis, Fusobacterium nucleatum, and Escherichia coli.
• Analysis of studies investigating the link between these bacteria and colorectal cancer.
• Synthesis of evidence regarding their inflammatory and oncogenic mechanisms.

Main Results:

• Bacteroides fragilis, Fusobacterium nucleatum, and Escherichia coli are identified as potentially pathogenic in the context of colorectal cancer.
• These bacteria contribute to colorectal carcinogenesis via inflammatory pathways.
• Evidence suggests oncogenic properties associated with these specific gut microbes.

Conclusions:

• The gut microbiota, particularly specific species like B. fragilis, F. nucleatum, and E. coli, plays a significant role in colorectal cancer.
• Understanding the pathogenic mechanisms of these bacteria is crucial for developing targeted therapeutic strategies.
• Further research into the interplay between gut microbiota and colorectal cancer is warranted.